Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 1
1951 1
1952 1
1955 2
1957 2
1958 3
1959 3
1960 2
1962 3
1963 4
1964 2
1965 5
1966 3
1967 5
1968 5
1969 8
1970 8
1971 8
1972 4
1973 4
1974 6
1975 6
1976 4
1977 15
1978 9
1979 13
1980 8
1981 6
1982 7
1983 5
1984 7
1985 10
1986 6
1987 5
1988 8
1989 8
1990 9
1991 7
1992 2
1993 2
1994 5
1995 9
1996 1
1997 4
1998 4
1999 2
2000 1
2001 2
2002 1
2003 4
2005 2
2006 1
2011 1
2012 1
2013 2
2017 1
2019 4
2020 1
2021 2
2022 5
2023 3
2024 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

276 results

Results by year

Filters applied: . Clear all
Page 1
Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric cancer (KEYNOTE-859): a multicentre, randomised, double-blind, phase 3 trial.
Rha SY, Oh DY, Yañez P, Bai Y, Ryu MH, Lee J, Rivera F, Alves GV, Garrido M, Shiu KK, Fernández MG, Li J, Lowery MA, Çil T, Cruz FM, Qin S, Luo S, Pan H, Wainberg ZA, Yin L, Bordia S, Bhagia P, Wyrwicz LS; KEYNOTE-859 investigators. Rha SY, et al. Lancet Oncol. 2023 Nov;24(11):1181-1195. doi: 10.1016/S1470-2045(23)00515-6. Epub 2023 Oct 21. Lancet Oncol. 2023. PMID: 37875143 Clinical Trial.
Docking Paradigm in Drug Design.
Sulimov VB, Kutov DC, Taschilova AS, Ilin IS, Tyrtyshnikov EE, Sulimov AV. Sulimov VB, et al. Among authors: ilin is. Curr Top Med Chem. 2021;21(6):507-546. doi: 10.2174/1568026620666201207095626. Curr Top Med Chem. 2021. PMID: 33292135 Review.
Chemical Adjustment of Fibrinolysis.
Shibeko AM, Ilin IS, Podoplelova NA, Sulimov VB, Panteleev MA. Shibeko AM, et al. Among authors: ilin is. Pharmaceuticals (Basel). 2024 Jan 10;17(1):92. doi: 10.3390/ph17010092. Pharmaceuticals (Basel). 2024. PMID: 38256925 Free PMC article.
Docking and other computing tools in drug design against SARS-CoV-2.
Sulimov AV, Ilin IS, Tashchilova AS, Kondakova OA, Kutov DC, Sulimov VB. Sulimov AV, et al. Among authors: ilin is. SAR QSAR Environ Res. 2024 Feb;35(2):91-136. doi: 10.1080/1062936X.2024.2306336. Epub 2024 Feb 14. SAR QSAR Environ Res. 2024. PMID: 38353209 Review.
New Chemicals Suppressing SARS-CoV-2 Replication in Cell Culture.
Sulimov A, Ilin I, Kutov D, Shikhaliev K, Shcherbakov D, Pyankov O, Stolpovskaya N, Medvedeva S, Sulimov V. Sulimov A, et al. Among authors: ilin i. Molecules. 2022 Sep 5;27(17):5732. doi: 10.3390/molecules27175732. Molecules. 2022. PMID: 36080498 Free PMC article.
[Nevoxanthoendothelioma].
Il'in II, Pasechnik VA. Il'in II, et al. Vestn Dermatol Venerol. 1971;45(4):76-80. Vestn Dermatol Venerol. 1971. PMID: 5002591 Russian. No abstract available.
[Lupus-carcinoma].
Lysenko OV, Il'in II. Lysenko OV, et al. Vestn Dermatol Venerol. 1979 Dec;(12):35-40. Vestn Dermatol Venerol. 1979. PMID: 525022 Russian. No abstract available.
276 results